Adiponectin, a key adipokine in obesity related liver diseases - Wikidata - wikimedia - TriplyDB

Adiponectin, a key adipokine in obesity related liver diseases

Adiponectin, a key adipokine in obesity related liver diseases

http://www.wikidata.org/entity/Q35061908

about

Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review Adiponectin agonist ADP355 attenuates CCl4-induced liver fibrosis in mice Free Radical-Scavenging, Anti-Inflammatory/Anti-Fibrotic and Hepatoprotective Actions of Taurine and Silymarin against CCl4 Induced Rat Liver Damage CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via upregulation of liver adiponectin receptors Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.Cot/tpl2 participates in the activation of macrophages by adiponectin.Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomics Nonalcoholic fatty liver disease: Diagnostic biomarkers.Effects of resveratrol and other polyphenols in hepatic steatosis.Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.Adiponectin isoforms differentially affect gene expression and the lipidome of primary human hepatocytes Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.Glucose and fatty acid metabolism in a 3 tissue in-vitro model challenged with normo- and hyperglycaemia Green tea polyphenols reduced fat deposits in high fat-fed rats via erk1/2-PPARγ-adiponectin pathway CD44 plays a critical role in regulating diet-induced adipose inflammation, hepatic steatosis, and insulin resistance Liver function parameters in hip fracture patients: relations to age, adipokines, comorbidities and outcomes.Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index.Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample Chemokine-like receptor 1 deficiency does not affect the development of insulin resistance and nonalcoholic fatty liver disease in mice Lipid abnormalities in alpha/beta2-syntrophin null mice are independent from ABCA1.Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic β cells and adipocytes Nature of fatty acids in high fat diets differentially delineates obesity-linked metabolic syndrome components in male and female C57BL/6J mice Inflammation and oxidative stress in obesity-related glomerulopathy Role of ceramides in nonalcoholic fatty liver disease Ablation of leptin signaling to somatotropes: changes in metabolic factors that cause obesity An in vivo screen of secreted proteins identifies adiponectin as a regulator of murine cutaneous wound healing.What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?Involvement of splenic iron accumulation in the development of nonalcoholic steatohepatitis in Tsumura Suzuki Obese Diabetes mice.Serum fetuin-A levels related with microalbuminuria in diet-induced obese rats.Common variants in adiponectin gene are associated with coronary artery disease and angiographical severity of coronary atherosclerosis in type 2 diabetes.Adipokines and hepatic insulin resistance Adipose Tissue Depots and Their Cross-Sectional Associations With Circulating Biomarkers of Metabolic Regulation Association of Adiponectin rs1501299 and rs266729 Gene Polymorphisms With Nonalcoholic Fatty Liver Disease.Maternal obesity is associated with the formation of small dense LDL and hypoadiponectinemia in the third trimester.Association of two Common Single Nucleotide Polymorphisms (+45T/G and +276G/T) of ADIPOQ Gene with Coronary Artery Disease in Type 2 Diabetic Patients.Chemokine-Like Receptor 1 mRNA Weakly Correlates with Non-Alcoholic Steatohepatitis Score in Male but Not Female Individuals Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.

P2860

Q24658601-B3BDC9F0-8EFE-4A05-9536-9719444A9C60 Q26766459-178CB2E0-D5EE-4A20-9AC5-311011F990D3 Q28543721-87980983-BA2D-44E2-8C74-D1692BD0F7E7 Q28551489-813A24A9-AEF9-451A-B4B2-2DEECE0185AA Q28610813-D8A22C90-87B6-4B49-A96B-A8946E3E7696 Q30241387-3F64001C-9642-4F31-9C93-989D6AF64FB6 Q33613182-AB620DEC-3C95-4949-9445-3A9BF1583DDF Q33688456-01EECAC0-C527-41A5-B9A2-57B372FB1921 Q33706254-FD1BBBE1-A5FC-42A5-82CC-D8C8EEFF68B0 Q33780166-9E62BFCC-23A3-4F17-A4D4-64C64D053BA1 Q33887123-BF34097C-1DD6-47ED-9C49-A1F6990E9074 Q33891750-695BF17C-A62D-4270-8301-BD91023B7F9D Q33912675-3870E413-49EB-42D2-86A1-05B745760BAA Q33948324-3BF7CF09-723F-46B0-B54F-2DA8F8F3B1E8 Q34235400-0EBD0938-1C14-47E4-8791-9AB2C000EE0F Q34558750-1E4B6CBB-9340-4CAF-A7D7-1ECDFDF8FB07 Q34625795-AC8A77FD-7DAD-4BFA-B5BE-F602D43B9808 Q34942815-5B0A0AAB-460E-4E1E-9B6A-C5E53EDD6CBA Q35045813-F88D8795-E8E4-4CB3-B2A5-43C4F340D2AF Q35137985-5CBA7812-2880-4EDE-A3D7-3674FB00FAA9 Q35159860-2B19F334-0FB2-4467-ABEB-86DFED6318AD Q35186664-00C37E9A-AE14-448E-9189-0883FD85904E Q35622533-B38395E1-7995-48B2-99DC-803D6DDA927C Q35683960-3A6BCFB4-C705-4FA9-8EFA-527282E1129E Q35750773-86E56687-7A80-4142-ACF1-39219325D1AC Q35904102-47EC2039-91D0-442F-848B-5DD9EFA34667 Q36129432-F4AC5A5D-3CC5-4BEE-A34C-DD2DCCEA302A Q36439387-444217D4-DB9E-4380-991A-533344E2B704 Q36610006-81BDE532-59AA-4D1A-BA8C-8D232A8EE59B Q36616784-163A179C-3636-4F95-9447-3F230A48E499 Q36638596-3A1C8EAB-7FF8-4ABD-ABC4-6C416261C0E0 Q36665115-04FCB79B-D547-4801-9E16-A881BAFD654D Q36828075-57F20DC6-6F06-47E1-AE88-E26CCC401520 Q36896425-4F463331-C259-4333-AF87-55B5681D0AD6 Q36956683-1D43459E-8FDC-452F-8BB3-043A878CBA29 Q37073866-A62C0303-5289-4934-86C9-D2CDA9D37158 Q37076750-EF4DFE48-55AF-4433-8941-73AACA78FA30 Q37106282-2C902569-8739-4270-A38D-C6E2C7E393BB Q37210183-62A24B8E-A60B-4667-B86E-3C148A857250 Q37375539-579F317D-455A-4674-AF67-73C8AFFC9365

P2860

Adiponectin, a key adipokine in obesity related liver diseases

http://www.wikidata.org/entity/Q35061908

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Adiponectin, a key adipokine in obesity related liver diseases

@ast

Adiponectin, a key adipokine in obesity related liver diseases

@en

type

label

Adiponectin, a key adipokine in obesity related liver diseases

@ast

Adiponectin, a key adipokine in obesity related liver diseases

@en

prefLabel

Adiponectin, a key adipokine in obesity related liver diseases

@ast

Adiponectin, a key adipokine in obesity related liver diseases

@en

P1433

Q35061908-3AB31BB7-DE35-41C7-B64E-270732EEB5C6

P1476

Q35061908-F48CAAAE-46FA-4609-855C-6C59E1D04178

P2093

Q35061908-BB630EC0-78CF-4081-9F59-1B8DA7CB9974

Q35061908-C79E4B64-FE7E-4648-8AF1-D2D3ECBCBF94

Q35061908-DC9BCBEC-EAF2-44D2-9631-2586002D5173

P2860

Q35061908-00191B4C-1C9C-4331-961D-BE6B80691083

Q35061908-003C3BFA-98D4-4090-B7F6-DF15D8C06D42

Q35061908-0379F249-D646-4AA2-B6C8-67F9F91DB347

Q35061908-0395BBEE-B83F-48B5-9567-0F5234A89EAC

Q35061908-03E17635-E486-40CF-B867-56048F0A2F94

Q35061908-09258742-9FF9-42D7-8B47-5921C6A68977

Q35061908-0A824286-FFD1-4AC1-A1E6-6ECA0C293066

Q35061908-0A926390-8F4B-438C-8E47-56B560883394

Q35061908-101CBA6A-C91B-4066-B048-935F59013D19

Q35061908-12887651-BE41-40F0-9E4E-2C9143CD2CE2

P304

Q35061908-630B194C-E498-418A-956D-DB36639BB32F

P31

Q35061908-CC0959DB-7D11-484A-B1AC-D98AF38360B4

P356

Q35061908-AF4D6A65-43CF-4C01-9A42-F7D36B2A78A7

P407

Q35061908-B6E276F2-CFEF-49E9-A767-17A048B27178

P433

Q35061908-0C95FFC4-FF31-4592-8A6D-D69B9DCD1307

P478

Q35061908-D7E12F44-48DE-4065-95E8-9265EDE5763D

P577

Q35061908-41B34F7F-63D4-45CB-BE9E-3A95CE461123

P5875

Q35061908-25B594D1-A5DD-4BF7-80F1-4E8B2E9F7E04

P698

Q35061908-80ACFBA5-B13E-4ABE-8BF4-9D519C2572E0

P921

Q35061908-80CAE792-CA93-4FAF-8913-D8C0AF57B16D

P932

Q35061908-822EA312-6FBA-4B90-84F0-47908A6802BC

P356

WJG.V17.I23.2801

P1433

World Journal of Gastroenterology

P1476

Adiponectin, a key adipokine in obesity related liver diseases

@en

P2093

Christa Buechler

http://www.w3.org/2001/XMLSchema#string

Josef Wanninger

http://www.w3.org/2001/XMLSchema#string

Markus Neumeier

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

Antioxidants prevent health-promoting effects of physical exercise in humans

Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30)

Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3)

Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

P304

2801-2811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V17.I23.2801

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51472685

http://www.w3.org/2001/XMLSchema#string

P698

21734787

http://www.w3.org/2001/XMLSchema#string

P921

P932

3120939

http://www.w3.org/2001/XMLSchema#string